Metaphedrone
| 3-MMC | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 177.24 g/mol [1] |
| Predicted LogP | 2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H15NO |
| IUPAC name | 2-(methylamino)-1-(3-methylphenyl)propan-1-one |
| SMILES | CC1=CC(=CC=C1)C(=O)C(C)NC |
| InChI | InChI=1S/C11H15NO/c1-8-5-4-6-10(7-8)11(13)9(2)12-3/h4-7,9,12H,1-3H3 |
| InChIKey | QDNXSIYWHYGMCD-UHFFFAOYSA-N |
| CAS number | 1246816-62-5 |
| UNII | 73Q9QTO1N4 |
| PubChem CID | 71741532 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 50 min (in pigs) |
| Routes of administration | Oral, Insufflated (most common), Injected |
| Dosing[] |
|---|
| Insufflated [] | |
|---|---|
| Light | ≤ 80.6 mg(100x - 30.2%) |
| Common | 80.6 - 98 mg(67x - 20.2%) |
| Strong | 98 - 120 mg(91x - 27.5%) |
| Heavy | 120 - 140 mg(45x - 13.6%) |
| Extreme | 140 mg +(28x - 8.5%) |
| Intravenous [] | |
|---|---|
| Light | ≤ 65 mg(292x - 43.5%) |
| Common | 65 - 80 mg(62x - 9.2%) |
| Strong | 80 - 120 mg(154x - 23.0%) |
| Heavy | 120 - 150 mg(99x - 14.8%) |
| Extreme | 150 mg +(64x - 9.5%) |
| Oral [] | |
|---|---|
| Light | ≤ 300 mg(25x - 42.4%) |
| Common | 300 - 330 mg(18x - 30.5%) |
| Strong | 330 - 340 mg(4x - 6.8%) |
| Heavy | 340 - 350 mg(10x - 16.9%) |
| Extreme | 350 mg +(2x - 3.4%) |
| Intrarectal [] | |
|---|---|
| Light | ≤ 65.9 mg(18x - 36.7%) |
| Common | 65.9 - 75 mg(11x - 22.4%) |
| Strong | 75 - 100 mg(14x - 28.6%) |
| Heavy | 100 - 120 mg(3x - 6.1%) |
| Extreme | 120 mg +(3x - 6.1%) |
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki) We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Metaphedrone (3-Methylmethcathinone) (also known as 2-(methylamino)-1-(3-methylphenyl)-1-Propanone, 1-Propanone, 2-(methylamino)-1-(3-methylphenyl)-, Dea no. 1259, 3-MMC compound, 824-776-2, 3-Methyl Methcathinone Hydrochloride, 3-methylmethcathinone (3-MMC), Wzb81662, Ds-016274 or 2-Methylamino-1-(3-methylphenyl)propan-1-one) is a stimulant substance of the cathinone class.
Chemistry
Stereochemistry []
Metaphedrone is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Metaphedrone matches Lipinski's rule of five.Reagents
There are currently 11 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no change or yellowish | |
| Mecke | no color change | |
| Mandelin | short orange / red / brownish > yellow | |
| Liebermann | yellow / orange | |
| Froehde | no color change | |
| Simon's | slow blue | |
| Ehrlich | no color change | |
| Hofmann | no color change | |
| Morris | purple | |
| Zimmermann | purple ring / brown | |
| Gallic | no color change |
Subjective effects []
| 0xea / Metaphedrone [] | |
|---|---|
Routes:
| |
| a1ko / Metaphedrone [] | |
|---|---|
Routes:
| |
| emily / Metaphedrone [] | |
|---|---|
Routes:
| |
| Mere / Metaphedrone [] | |
|---|---|
| michalina / Metaphedrone [] | |
|---|---|
| nervewing / Metaphedrone [] | |
|---|---|
| Pilz / Metaphedrone [] | |
|---|---|
Routes:
| |
Experience reports
Erowid
There are currently 17 experience reports involving metaphedrone on Erowid: []- "A Wonderful Addition to the Family" by Generous Slut
- "Jolts and Blood Pressure Drops" by Newbie
- "Beautiful Medicine" by Major Tom
- "Dangerous Euphoria" by doughy
- "For the Extra Focus" by happyentactogen
- "Warm and Cold at the Same Time" by leinad
- "An Overview of Intravenous Cathinone Usage" by Infectious
- "Accidental Overdose, Panicking for Hours" by Love Witch 66
- "Toxic, Avoid" by Dave
- "Slow Come Up, but Immensely Pleasurable" by Magic
- "Long Usage" by Lust
- "Weak Substitute No Way" by Perrydiculous
- "More than MDMAlite" by Randy
- "I'm Confused, Flabbergasted..." by bladeasap
- "Dark K Trip After a Night of Stimulants" by Anonymous
- "Come as Waves" by GNUswami
- "Good Feeling" by SAMI
Legal status []
- Brazil: Metaphedrone is a F2.
- United Kingdom: Metaphedrone is a Class B under the "Misuse of Drugs Act 1971".
- United States: Metaphedrone is a Schedule I under the "Controlled Substances Act".
- Germany: Metaphedrone is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
- United Nations: Metaphedrone is a Schedule II psychotropic under the "Convention on Psychotropic Substances 1971".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 71741532, Metaphedrone. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/71741532
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Metaphedrone. UNII: 73Q9QTO1N4. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/73Q9QTO1N4
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | ok | 2026-11-20 09:34:14 |
| drugspro | ok | 2026-11-20 09:34:10 |
| erowid | ok | 2026-11-20 09:34:12 |
| gsrs | ok | 2026-11-20 09:34:10 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0245933) | 2026-11-20 09:34:10 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 09:34:15 |
| pubchem | ok | 2026-11-20 09:34:08 |
| ok | 2026-11-20 09:34:10 | |
| sider | missing (not in SIDER) | 2026-11-20 09:34:10 |
| structure | ok | 2026-11-20 09:34:10 |
| wikipedia | ok | 2026-11-20 09:34:10 |